Project Grant K23DK147757
- Federal Grant Award Summary Columbia University's Health Sciences Division received a $821,018 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026, with a completion date of February 28, 2031. The award funds basic biomedical research investigating the immunological mechanisms underlying celiac disease (CD), specifically examining...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The University of Texas Southwestern Medical Center a $249,000 Project Grant (R03) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 9, 2025, for research investigating genetic susceptibilities to celiac disease. The award, which extends through August 31, 2027, supports innovative genomic research utilizing next-generation...
- Grant Award Summary Cleveland Clinic Lerner College of Medicine of Case Western Reserve University received a $614,625 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award was obligated on June 15, 2026, with a completion date of March 31, 2030. The research will be conducted at the institution's Cleveland, Ohio facility. The grant funds fundamental...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Colorado-Denver a $192,826 Project Grant effective July 1, 2026, through March 31, 2031, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds comparative effectiveness research evaluating advanced therapies—including biologics and small molecule treatments—used to treat pediatric Crohn's disease. The research...
- Federal Project Grant Award Summary Yale University received a $2.33 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 17, 2026, with completion targeted for April 30, 2031. The award funds laboratory-based research to advance understanding of celiac disease (CD) pathogenesis and develop clinically useful biomarkers for disease activity assessment. The project applies...
- Federal Grant Award Summary Cleveland State University's Office of Sponsored Programs & Research received a $552,763 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 15, 2026, with completion targeted for January 31, 2029. The award supports basic biomedical research investigating the functional role of STAG1 (a cohesin...
- Federal Project Grant Award Summary The University of Colorado-Denver received a $234,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through September 14, 2027. The award funds research investigating the role of AIOLOS, a transcriptional repressor protein, in T cell-mediated pathogenesis of inflammatory bowel...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Tufts Medical Center a K23 Mentored Patient-Oriented Research Career Development Award totaling $191,547 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, announced on September 15, 2025, with a completion date of July 31, 2030, funds Dr. Sushrut Jangi's research development as an independent clinician scientist focused on...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $375,576 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 1, 2025, with completion targeted for April 30, 2030. The award supports research focused on developing predictive models of CD-68 inflammatory and anti-inflammatory...
- Federal Grant Award Summary Mayo Clinic received a $2.84 million Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 22, 2025, through September 21, 2029. This award funds research to elucidate the genetic regulation of epithelial injury in ulcerative colitis (UC) and identify predictive biomarkers for anti-tumor necrosis factor...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant of $181,195.00 to Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, effective June 15, 2026, through April 30, 2031, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a research training program titled "Personalized Approach to Celiac Disease Diagnosis (PACKED Study)" led by principal investigator Dr. Claire Jansson-Knodell in the Department of Gastroenterology at Cleveland Clinic Foundation. The funded research deliverables include development and validation of a clinical prediction model that integrates clinical patient data with tissue transglutaminase immunoglobulin A (TTG-IgA) antibody levels to improve celiac disease diagnosis. The model is designed to stratify patients into three risk categories—low, intermediate, and high likelihood—thereby reducing unnecessary invasive testing such as upper endoscopy and duodenal biopsy while maintaining diagnostic accuracy. Under the mentorship of celiac disease expert Dr. Rubio-Tapia and biostatistician Dr. Dalton, along with a supporting committee, the research aims to advance patient-centered care and decrease healthcare costs through a personalized diagnostic approach that replaces the current standardized testing protocol applied uniformly to all patients.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $181.2k | 6/8/26 |